Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Completed

Plain-English translation of NCT02709512 on ClinicalTrials.gov ↗ · Source last updated October 2023 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(45 sites)

United States

Mayo Clinic, Phoenix, Arizona

UCLA Hematology & Oncology - Santa Monica, Los Angeles, California

University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, California

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

University of Chicago, Chicago, Illinois